-
1 Comment
Trans Genic Inc is currently in a long term downtrend where the price is trading 4.8% below its 200 day moving average.
From a valuation standpoint, the stock is 98.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.9.
Trans Genic Inc's total revenue rose by 17.7% to $3B since the same quarter in the previous year.
Its net income has increased by 2160.5% to $423M since the same quarter in the previous year.
Based on the above factors, Trans Genic Inc gets an overall score of 3/5.
| Exchange | TSE |
|---|---|
| CurrencyCode | JPY |
| ISIN | JP3635720000 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Beta | 0.53 |
|---|---|
| PE Ratio | None |
| Target Price | None |
| Market Cap | 3B |
| Dividend Yield | None |
Transgenic Group Inc. develops, distributes, and licenses genetically modified animals and antibodies in Japan. It operates through Drug Discovery Support Business and Investment Business segments. The company provides glycan synthesis and analysis services; non-clinical studies for pharmaceuticals, foods, cosmetics, chemical substances, etc., as well as various safety tests for foods, and pharmaceutical agents; and support for bioequivalence test, including clinical trials, pharmacokinetic measurements, and the preparation of clinical trial reports; as well as hospital support services. It also offers drug efficiency and pharmacological test and safety studies; sugar chain analysis and synthesis services; advice and support services, including M&A, business revitalization, business succession services; and contract production services, such as genetically modified mice, antibodies, protein hypers, and expressing cells, as well as sells mouse-related products and mouse models, and research reagents. The company was formerly known as Trans Genic Inc. and changed its name to Transgenic Group Inc. in October 2024. Transgenic Group Inc. was incorporated in 1998 and is headquartered in Fukuoka City, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 2342.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
